| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |